Improving Quality of Life for Patients With Cystic Fibrosis CME

Author Information and Disclosures

Release Date: February 26, 2008; Valid for credit through February 26, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Novartis
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the pathogenesis of cystic fibrosis, clinical manifestations of the disease, and diagnostic testing
  2. Review current pharmacologic and nonpharmacologic treatment options for cystic fibrosis
  3. Discuss the importance of adherence to treatment and identify possible barriers to adherence
  4. Recognize the importance of a multidisciplinary team approach to patient care
Authors and Disclosures

Noah Lechtzin, MD, MHS
Disclosure: Noah Lechtzin, MD, MHS, has disclosed no relevant financial relationships.


Margaret A. Clark, RN, RRT-NPS
Disclosure: Margaret A. Clark, RN, RRT-NPS, has disclosed no relevant financial relationships.


Christopher J. Lettieri, MD
Disclosure: Christopher J. Lettieri, MD, has disclosed no relevant financial relationships.


 
University of Kentucky
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the University of Kentucky College of Medicine. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their fields.

The University of Kentucky is an Equal Opportunity University.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.